Showing results (101-110 of 116) with videos related to
Sort By:
Pageof 12
Molecular Cancer Therapeutics|August 14, 2020
Preclinical Antitumor Activity and Biodistribution of a Novel Anti-GCC Antibody-Drug Conjugate in Patient-derived XenograftsAdnan O Abu-Yousif, Donna Cvet, Melissa Gallery, et al.Bioorganic & Medicinal Chemistry Letters|January 26, 2016
Optimization of tetrahydronaphthalene inhibitors of Raf with selectivity over hERGShih-Chung Huang, Sharmila Adhikari, Roushan Afroze, et al.Clinical and Translational Allergy|November 18, 2025
Sebetralstat for On-Demand Treatment of Mucosal Hereditary Angioedema Attacks in KONFIDENT-SJonathan A Bernstein, Emel Aygören-Pürsün, Mauro Cancian, et al.Science (New York, N.Y.)|June 7, 2003
Morphology and composition of the surface of Mars: Mars Odyssey THEMIS resultsPhilip R Christensen, Joshua L Bandfield, James F Bell, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 5, 2026
Impact of Oral Sebetralstat on Anxiety Associated With Hereditary Angioedema AttacksTimothy Craig, Emel Aygören-Pürsün, Jonathan A Bernstein, et al.Lancet (London, England)|February 11, 2023
An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trialEmel Aygören-Pürsün, Andrea Zanichelli, Danny M Cohn, et al.Space Science Reviews|September 27, 2021
The Emirates Mars Mission (EMM) Emirates Mars InfraRed Spectrometer (EMIRS) InstrumentChristopher S Edwards, Philip R Christensen, Greg L Mehall, et al.The New England Journal of Medicine|May 31, 2024
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema AttacksMarc A Riedl, Henriette Farkas, Emel Aygören-Pürsün, et al.The Journal of Allergy and Clinical Immunology. Global|July 12, 2026
Sebetralstat for breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis in KONFIDENT-STamar Kinaciyan, Emel Aygören-Pürsün, Inmaculada Martinez-Saguer, et al.The Journal of Allergy and Clinical Immunology. in Practice|August 31, 2025
Long-term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label ExtensionHenriette Farkas, John Anderson, Laurence Bouillet, et al.Pageof 12